New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 21, 2014
09:07 EDTWUBA, KIN, SSI, SMTC, SHLD, AUXL, ISIL, GES, AMPE, MCC, IFNNY, KIRKOn The Fly: Pre-market Movers
HIGHER: Semtech (SMTC), up 3.4% after Bloomberg says that the Infineon (IFNNY) deal positions Intersil (ISIL) and Semtech for good fortune... Auxilium (AUXL), up 3.8% after announcing positive data from Phase 2a study of CCH with cellulite. DOWN AFTER EARNINGS: Sears (SHLD), down 2.6%... Kirkland's (KIRK), down 9.4%... Stage Stores (SSI), down 7%... 58.com (WUBA), down 8.8%. ALSO LOWER: Guess (GES), down 4.2% after disclosing resignation of Chief Design Officer... Medley Capital (MCC), down 2.5% after filing to sell 5M shares of common stock... Kindred Biosciences (KIN), down 28.1% after reporting that the company's pivotal field study of CereKin did not meet its primary endpoint... Ampio (AMPE), down 18.5% after delaying data analysis of STEP Study due to temperature deviations...
News For SHLD;KIRK;GES;SMTC;IFNNY;ISIL;SSI;MCC;AUXL;KIN;AMPE;WUBA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
16:35 EDTAUXLEndo sees Auxilium transaction immediately accretive
Endo International plc (ENDP)announced it has completed the acquisition of Auxilium Pharmaceuticals (AUXL) in a transaction valued at $2.6B when announced on October 9, 2014. The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders on January 27 and the receipt of all required regulatory approvals. Rajiv De Silva, president and CEO of Endo, stated, This strategic transaction enhances the organic growth of our branded pharmaceuticals business by adding a broad range of high quality products to our already robust portfolio and expanding our development pipeline. We are excited to deliver on the promise of this combination by leveraging our resources to enhance the performance of XIAFLEX and optimize TESTOPEL and STENDRA. We continue to expect the transaction to be immediately accretive for shareholders and meaningfully accretive each year moving forward. We believe that Endo is now even better positioned to drive growth across our product portfolio and to capitalize on additional future strategic M&A opportunities to create value for shareholders, customers and employees." Auxilium common stock will cease to be traded on the NASDAQ Global Market following the close of trading on January 29.
09:22 EDTISILIntersil upgraded to Buy from Hold at Craig-Hallum
Subscribe for More Information
05:54 EDTIFNNYInfineon sees FY15 revenue growth 12%, plus or minus two points
Subscribe for More Information
05:52 EDTIFNNYInfineon sees Q2 revenue growth 5%-9%
Subscribe for More Information
05:52 EDTIFNNYInfineon reports Q1 net income EUR 136M vs. EUR 87M last year
Subscribe for More Information
January 28, 2015
16:20 EDTISILIntersil sees Q1 EPS 14c-16c, consensus 15c
Subscribe for More Information
16:19 EDTISILIntersil reports Q4 EPS 18c, consensus 14c
Reports Q4 revenue $131.1M, consensus $128.74M.
11:03 EDTSHLDSears reduces headcount at corporate locations, Chicago Tribune says
Subscribe for More Information
January 27, 2015
13:55 EDTAMPEAmpio mentioned cautiously by Seeking Alpha contributor
Reference Link
10:00 EDTKIRKOn the Fly: Analyst Downgrade Summary
Subscribe for More Information
09:35 EDTAUXLAuxilium shareholders approve merger with Endo
Subscribe for More Information
06:39 EDTKIRKKirkland's downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Kirkland's to Neutral saying the company's sales in Texas, which represent 19% of the store base, may be weak amid declining oil prices. Piper keeps a $24 price target for shares.
06:06 EDTSHLDSears Holdings volatility increases, shares in tight two-month price range
Subscribe for More Information
January 22, 2015
14:03 EDTAUXLAuxilium to host special shareholder meeting
Subscribe for More Information
08:04 EDTAMPEAmpio subsidiary secures European distribution for RedoxSYS diagnostic system
Ampio subsidiary Luoxis Diagnostics has secured long-term agreements with European distributors Eurobio, Una Health Limited, and THP Medical, to offer Luoxis' RedoxSYS Diagnostic System to academic and pharma-based research centers within their respective territories. RedoxSYS is a diagnostic platform and robust research tool capable of measuring oxidation-reduction potential in the body in response to injury, illness, or stress. Eurobio was granted territorial rights to offer RedoxSYS to institutions based in France and Switzerland, while Una Health Limited and THP Medical were granted territorial rights to the U.K. and Austria, respectively. These are multi-year agreements with the option to renew at the 3-5 year mark.
January 21, 2015
12:12 EDTSHLDBest Buy, home retailers seen getting biggest bump from Sears demise
Subscribe for More Information
January 20, 2015
12:01 EDTSHLDOverstock.com to appeal patent infringement case
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use